Name: Haibo Xu

Country: China

Affiliation:

Department of Pharmacology, State Key Laboratory for Research and Development of Chinese Materia Medica, Chengd University of Traditional Chinese Medicine.

Phone no: +86-13908197368

Email: Send an Email


Address:

Department of Pharmacology School of Pharmacy Chengdu University of Traditional Chinese Medicine 1166 Liutai Avenue Wenjiang, Chengdu, Sichuan P.R. China 611137

Research Interests:

pathogenesis of gastrointestinal cancer, hepatitis, hypertension, and the therapeutic intervention in these diseases with traditional Chinese medicine, along with the delineation of the underlying mechanisms for Chinese herbal effects.

Biography:

  • Dr. Haibo Xu is a professor in the department of pharmacology, school of pharmacy, at the Chengdu University of Traditional Chinese Medicine (TCM), Sichuan, China. 
  • He got a bachelor's degree in medicine at the Southwest Medical University in China in 1997, a master's degree in pharmacology at the Guangzhou University of TCM in 2000, and a PhD in molecular pharmacology at the Guangzhou University of TCM in 2003, followed by his 6-month lectureship in the institute of gastroenterology, Guangzhou University of TCM, Guangdong, China. 
  • From March 2004 to February 2007, Dr. Xu was a postdoctoral research fellow in cancer biology in the department of surgery, centre for cancer research and cell biology, Queen’s University Belfast, UK, followed by another over 3-year research on hypertension in the school of physiology and pharmacology in the University of Bristol, UK. 
  • Dr. Xu has been holding several research grants as a principle investigator in China, with 40 published papers and 6 oral presentations in international conferences. 
  • He was awarded the European Investigators’ Travel Grant by the 19th European meeting on hypertension in Milan, organized by the European Society of Hypertension in 2009. 
  • He also received 4 travel grants from British Heart Foundation, Physiological Society of UK and the Cancer Recognised Research Group of Northen Ireland.